93 related articles for article (PubMed ID: 11745230)
1. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.
Lazzarotto-da-Silva G; Grezzana-Filho TJM; Scaffaro LA; Farenzena M; Silva RK; de Araujo A; Arruda S; Feier FH; Prediger L; Lazzaretti GS; Alvares-da-Silva MR; Chedid AD; Kruel CRP; Chedid MF
Langenbecks Arch Surg; 2023 Jan; 408(1):26. PubMed ID: 36639606
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma.
Yuan-Dong S; Hao Z; Hui-Rong X; Jing-Zhou L; Hui-Yong W; Jian-Jun H; Yu JM
Medicine (Baltimore); 2019 Dec; 98(49):e18030. PubMed ID: 31804309
[TBL] [Abstract][Full Text] [Related]
4. Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO-HBP-005): Clinical Study Group of Osaka University, Hepato-Biliary-Pancreatic Group.
Kobayashi S; Tomokuni A; Takeda Y; Wada H; Katsura Y; Hashimoto K; Tomimaru Y; Asaoka T; Yamada T; Tsujie M; Noda T; Morita S; Nagano H; Mori M; Doki Y; Eguchi H;
Hepatol Res; 2024 Jan; ():. PubMed ID: 38279693
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of novel combined surgical-injection treatment (COSIT) for large hepatocellular carcinoma: Stage 2A IDEAL prospective case series.
Elsanousi OM; Mohamed MA; Salim FH; Adam EA; Bedri S
Ann Med Surg (Lond); 2021 Dec; 72():103098. PubMed ID: 34888043
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis.
Guo P; Zheng J; Pi X; Gao F; Zhao Y; Xie C; Cao W
Front Oncol; 2024; 14():1283843. PubMed ID: 38646438
[TBL] [Abstract][Full Text] [Related]
7. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of ablative and non-surgical therapies for early hepatocellular carcinoma: Systematic review and network meta-analysis of randomised controlled trials.
South E; Wade R; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Dias S; Simmonds M; Rowe I; Thornton P; Wah TM; Eastwood A
Cancer Med; 2023 Nov; 12(22):20759-20772. PubMed ID: 37902128
[TBL] [Abstract][Full Text] [Related]
9. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.
Kim HI; An J; Han S; Shim JH
Clin Mol Hepatol; 2023 Oct; 29(4):1013-1028. PubMed ID: 37403319
[TBL] [Abstract][Full Text] [Related]
10. Treatment of a huge biloma complicating curative radiofrequency ablation of hepatocellular carcinoma: a case report.
Wang H; Yan Z; Wang J; Zou Y
J Int Med Res; 2019 Oct; 47(10):5337-5342. PubMed ID: 31526172
[TBL] [Abstract][Full Text] [Related]
11. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children.
Jiang Y; Zhou S; Shen G; Jiang H; Zhang J
Medicine (Baltimore); 2018 Oct; 97(42):e12607. PubMed ID: 30334945
[TBL] [Abstract][Full Text] [Related]
12. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis.
Xie H; Yu H; Tian S; Yang X; Wang X; Yang Z; Wang H; Guo Z
Oncotarget; 2017 Nov; 8(59):100508-100523. PubMed ID: 29245997
[TBL] [Abstract][Full Text] [Related]
13. New idea for treatment strategies for Barcelona Clinic Liver Cancer stages based on a network meta-analysis.
Li K; Wang HT; He YK; Guo T
Medicine (Baltimore); 2017 May; 96(20):e6950. PubMed ID: 28514316
[TBL] [Abstract][Full Text] [Related]
14. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for cancer using X-ray fluorescence emitted from iodine.
Tamura M; Ito H; Matsui H
Sci Rep; 2017 Mar; 7():43667. PubMed ID: 28252657
[TBL] [Abstract][Full Text] [Related]
16. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison.
Zhao J; Zhang H; Wei L; Xie S; Suo Z
Oncotarget; 2017 Feb; 8(9):15101-15113. PubMed ID: 27835871
[TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
Lan T; Chang L; Mn R; Wu L; Yuan YF
Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
[TBL] [Abstract][Full Text] [Related]
18. Effect of microbubble-enhanced ultrasound on percutaneous ethanol ablation of rat walker-256 tumour.
Gao W; Qiao L; Gao Y; Zhang L; Zhang D; Tu J; Liu Z; Xie F
Eur Radiol; 2016 Sep; 26(9):3017-25. PubMed ID: 26676561
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Fu Y; Zhao X; Yun Q; Zhu X; Zhu Y; Li Q; Hu K; Wang J; Qiao Z
Int J Clin Exp Med; 2015; 8(7):10388-400. PubMed ID: 26379829
[TBL] [Abstract][Full Text] [Related]
20. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?
Di Costanzo GG; Tortora R
World J Hepatol; 2015 May; 7(9):1184-91. PubMed ID: 26019734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
